COGNITO THERAPEUTICS
Cognito Therapeutics is focused on discovering and developing new Alzheimer's treatments and preventive therapies. Founded in 2016, the company is based in Cambridge, Massachusetts, United States.
COGNITO THERAPEUTICS
Industry:
Health Care Health Diagnostics Medical Device
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.cognitotx.com
Total Employee:
11+
Status:
Active
Contact:
857-201-5088
Total Funding:
53.33 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag Mobile Non Scaleable Content Euro Google Analytics 4 ProfessionalService Schema
Similar Organizations
AMPRION
Amprion is a biotech company that focuses on the diagnosis for brain diseases.
Apertor Pharmaceuticals
Apertor is discovering and developing new treatments for age-related diseases.
InVivo Therapeutics
InVivo Therapeutics is a medical device company focused on developing restoration treatments for patients with spinal cord-injuries.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
NinePoint Medical
NinePoint Medical is a transformational medical device company developing innovative, real-time, in vivo pathology devices.
Current Employees Featured
Zach Malchano President @ Cognito Therapeutics
President
2016-01-01
Martin Williams VP, BD and Strategic Partnerships @ Cognito Therapeutics
VP, BD and Strategic Partnerships
2016-07-01
Brent Vaughan Chief Executive Officer @ Cognito Therapeutics
Chief Executive Officer
2020-09-01
Mihaly Hajos CSO @ Cognito Therapeutics
CSO
2019-05-01
Ed Boyden Co Founder @ Cognito Therapeutics
Co Founder
2016-07-01
Divya Dhar VP of Products @ Cognito Therapeutics
VP of Products
2021-10-01
Everett Crosland Chief Commercial Officer @ Cognito Therapeutics
Chief Commercial Officer
Li-Huei Tsai Co-Founder @ Cognito Therapeutics
Co-Founder
Founder
Official Site Inspections
http://www.cognitotx.com Semrush global rank: 2.25 M Semrush visits lastest month: 8.49 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Cognito Therapeutics"
Cognito Therapeutics
Info@cognitotx.com. Linkedin Twitter. Menu. Close. Evoking neuronal activity to improve the lives of Alzheimer’s patients. Our Science. Scroll Down. Our novel therapy is designed to evoke …See details»
Cognito Therapeutics - Crunchbase Company Profile
Contact Email info@cognitotx.com Phone Number 857-201-5088 Cognito Therapeutics is a clinical-stage neurotechnology business focused on creating …See details»
Cognito Therapeutics San Francisco - Crunchbase
Cognitotx.com ; 1,582,610; Highlights. Employee Profiles 1. Similar Companies 8. Recent News & Activity. There is no recent news or activity for this profile. ...See details»
Science | Cognito Therapeutics - GoDaddy
Info@cognitotx.com. Linkedin Twitter. Menu. Close. Cognito's headset design concept. O u r S c i e n c e. O u r s c i e n c e. Our non-invasive therapeutic intervention delivers proprietary visual …See details»
Cognito Therapeutics Strengthens Executive Team to Drive Next …
Feb 13, 2025 Cognito is committed to developing transformative, technology-driven interventions to address unmet needs in the treatment of CNS diseases. Cognito is headquartered in …See details»
Cognito Therapeutics (USA) Funding: $216.8M
Apr 2, 2025 USA | Funding: $216.8M Website: https://www.cognitotx.com Cognito Therapeutics is a neurotechnology company that is developing disease-modifying treatments for CNS …See details»
Cognito Therapeutics - Overview, News & Similar companies
Jan 29, 2024 Cognito Therapeutics contact info: Phone number: (857) 201-5088 Website: www.cognitotx.com What does Cognito Therapeutics do? Cognito Therapeutics is a pioneer in …See details»
Cognito Therapeutics Raises $73M Series B to Advance
Mar 22, 2023 Prior to Medtronic, he was the founder and chief scientific officer of the Harvard Clinical Research Institute, now the Baim Institute, a university-based contract research …See details»
Clinical Studies | Cognito Therapeutics - GoDaddy
Info@cognitotx.com. Linkedin Twitter. Menu. Close. Clinical Studies. Clinical studies. We are committed to rigorous clinical research to demonstrate the effectiveness of our treatment. Scroll Down. We have successfully completed …See details»
Cognito Therapeutics to Present New Data for …
Oct 7, 2024 Cognito is committed to developing transformative, technology-driven interventions to address unmet needs in the treatment of CNS diseases. Cognito is headquartered in Cambridge, MA. For more information, visit …See details»
Cognito Therapeutics Receives FDA Breakthrough Device …
CAMBRIDGE, MASSACHUSSETTS — Cognito Therapeutics, a clinical-stage company leading the development of a new class of disease-modifying digital therapeutics to treat …See details»
Cognito Therapeutics to Announce New Clinical Data Evaluating …
Mar 2, 2021 A replay of the symposium panel will be posted on Cognito’s website at www.cognitotx.com.. About Cognito Therapeutics. Cognito Therapeutics is a clinical-stage …See details»
Cognito Therapeutics Raises $73M Series B to Advance …
Mar 22, 2023 Prior to Medtronic, he was the founder and chief scientific officer of the Harvard Clinical Research Institute, now the Baim Institute, a university-based contract research …See details»
Resources | Cognito Therapeutics - GoDaddy
Info@cognitotx.com. Linkedin Twitter. Menu. Close. Resources. Resources. Read recent press, publications, and announcements about Cognito and our Alzheimer’s treatment. Scroll Down. …See details»
Cognito Therapeutics Announces First Patient Enrollment in
Feb 21, 2023 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Cognito Therapeutics, a clinical-stage neurotechnology company, announced today the first patient enrollment in its US pivotal study …See details»
Cognito Therapeutics Raises $73M in Series B | citybiz
Mar 22, 2023 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, …See details»
Cognito Therapeutics Careers - Levels.fyi
Cognito Therapeutics is a leading company in non-invasive neuromodulation for neurodegenerative diseases and cognitive enhancement. Their investigational therapy has …See details»
Careers | Cognito Therapeutics - GoDaddy
Info@cognitotx.com. Linkedin Twitter. Menu. Close. Careers. Careers. At Cognito, we’re creating more treatment options for Alzheimer’s patients. Join our team and become a part of our …See details»
Concentra® Announces Closing of Pivot Onsite Innovations …
7 hours ago “The goal for the streamlined single organization is to build on the past decades of providing high-quality service to customers while offering advancement opportunities for our …See details»
Privacy Policy and Terms of Service - cognitotx.com
If you have any questions, comments, or concerns about our processing activities, please email us at info@cognitotx.com. Home Our Science Clinical Studies About Resources Careers. …See details»